Investment highlights
Intellectual Asset
Advance patents for eye-drop therapeutic platform for retinal diseases
Peptide delivery platform → Advantageous position for expediting innovations
Market Growth
Market size and demand continues to grow rapidly due to increased average lifespans
Quick entry into addressable market
Competitiveness
Differentiated technology & product from existing developers
Accumulative Data
Verified data accumulated through joint research and collaboration with leading research institutes
Strong research capabilities through NT R&D Center
TEAM
(Managements + Researchers)
Competitive management team
Global risk management capabilities
